Bio-Techne Corporation (TECH) earnings on May 6, 2026
More Bio-Techne Corporation earnings
Prior outlook: Pessimistic Outcome: Accurate
TECH dropped sharply after reporting earnings that missed expectations. Profit per share and revenue were both lower than analysts forecast.
TECH price around the earnings
47.41
Change: -16.4%
2026-05-06, 20:00 UTC
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: Pessimistic Outcome: Accurate
- Thesis published
Negative outlook, price may fall further.
The company recently reported earnings and sales that fell short of expectations. This miss confirms a negative outlook, suggesting that the stock's recent performance reflects underlying weakness.
Context analyzed before publication
- Summary
- Negative outlook, the scenario is pessimistic.
- Playbook
- Given the missed earnings and negative sentiment, the scenario is pessimistic. The data points to a need for signs of fundamental improvement before the scenario shifts.
- Trend
- Negative trend confirmed after earnings miss.
Analysts
Drivers
-
Analysts
Negative
Although the average price target is high, one analyst recently reduced their target, reflecting some analyst caution.
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.64
- Analysts covering the stock
- 11
- Average price target
- 72.27
- Lowest price target
- 54
- Highest price target
- 80
- Upside to price target
- 45.7%
- Quarterly earnings growth
- 8.9%
- Revenue growth
- -0.4%
- Forward EPS
- 2.16
- Trailing EPS
- 0.53
- Analyst moves in the last 60 days
- 1
- Strong buy: 1
- Buy: 9
- Hold: 4
- Sell: 0
- Strong sell: 0
- Strong buy
- 1
- Buy
- 9
- Hold
- 4
- Sell
- 0
- Strong sell
- 0
- April 6, 2026 · Evercore ISI Group: Maintains rating (In-Line → In-Line)
News and sentiment
Drivers
-
News & sentiment
Negative
Actual Q3 earnings per share and sales missed expectations, signaling fundamental weakness after the event.
Evidence
Sentiment
- Sentiment
- Neutral
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (3)
- Bio-Techne Q3 2026 Earnings Call: Complete Transcript — Benzinga
- Bio-Techne Q3 Adj. EPS $0.53 Misses $0.54 Estimate, Sales $311.415M Miss $317.093M Estimate — Benzinga
- Evercore ISI Group Maintains In-Line on Bio-Techne, Lowers Price Target to $54 — Benzinga
Technicals
Drivers
-
Technical
Negative
A significant drop in price over the last 14 days and underperformance compared to the broader market indicate a pessimistic trend.
Evidence
- Average true range (ATR)
- 6%
- Distance to 52-week high
- -31.3%
- 14-day change (14d)
- -15.6%
- 30-day change
- -5.2%
- 30-day relative strength
- -17.2%
- Benchmark change
- +12.1%
- Nearest support
- 49.68
- Nearest resistance
- 62.19
- Volume accumulation ratio
- 1.08
Trends
Evidence
- Average earnings surprise
- +2.6%
- May 6, 2026: actual EPS 0.53 vs estimate 0.53 (surprise -0.8%)
- February 4, 2026: actual EPS 0.46 vs estimate 0.43 (surprise +5.8%)
- November 5, 2025: actual EPS 0.42 vs estimate 0.42 (surprise -0.4%)
- August 6, 2025: actual EPS 0.53 vs estimate 0.5 (surprise +5.8%)
Expected move
Drivers
-
Past earnings
Neutral
The company's historical performance shows a mixed record of beating earnings estimates, with small average surprises.
There is no implied-move data available for this event.
Reactions over its last 19 earnings
- Median move
- 3.7%
- 75th percentile move
- 7.2%
- 90th percentile move
- 8.9%
- Up / down moves
- 11 / 8
- Average up move
- +5.7%
- Average down move
- -3.8%
Monitoring and close
What Bio-Techne Corporation reported
There is no monitoring data available for this event.
Pre-market second reading after the results
There is no second reading available for this event.
How the stock reacted
- Outcome
- Accurate
- Consolidated
- -16.4%
- Max favorable move (MFE)
- 20.3%
- Max adverse move (MAE)
- 0%